Depressive illness, the sympathetic nervous system and cardiac risk

Journal of Hypertension

Volumn 27, Issue 12, 2009, Pages 2349-2350

  Esler, Murray ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADRENERGIC SYSTEM; ANXIETY DISORDER; CARDIOVASCULAR RISK; DEPRESSION; HUMAN; HYPERTENSION; NOTE; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL;

EID: 73649126248     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328332d1d5     Document Type: Note

References (21)

1. Frasure-Smith N, Lesperanoe F, Talajiic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993; 270:1819-1861.
2. Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, ef al., for the INTERHEART investigators. Association of psychological risk factors with risk of acute myocardial Infarction in 11, 119 cases and 13,648 controls from 52 countries (the INTERHEART study): a case-control study. Lancet 2004; 364:953-962.
3. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease. Arch Gen Psychiatry 1998; 65:580-592.
4. Bunker SJ, Colquhoun DM, Esler MD, Hickie IB, Hunt D, Jelinek M, et al. Stress and coronary heart disease: psychological risk factors. National Heart Foundation of Australia position statement update. Med J Aust 2003; 178:272-276.
5. GlassmanAH,ShapiroPA.Depressionandthecourseofcoronaryarterydisease. AmJPsychiatry1998;155:4-11.(Pubitemid28037542)
6. Esler M, Turbott J, Schwarz R, Leonard P, Bobik A, Skews H, Jackman G. The peripheral kinetics of norepinephrine in depressive illness. Arch Gen Psychiatry 1982; 9:295-300.
7. Scalco AZ, Rondon MUPB, Trombetta IC, Laterza MC, Azul JBCCS, Pullenayegum EM, et al. Muscle sympathetic nervous activity in depressed patients before and after treatment with sertraline. J Hypertens 2009; 27:2429-2436.
8. Barton DA, Dawood T, Lambert EA, Esler MD, Haikerwal D, Hotchkin E, et al. Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? J Hypertens 2007; 25:2117-2124.
9. Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence for a selective increase in resting cardiac sympathetic activity in some patients suffering sustained out of hospital ventricular arrhythmias. W Engl J Med 1991; 326:613-624.
10. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol 1995; 28:1267-11263
11. Brunner-La Rocca HP, Esler MD, Jennings GL, Kaye DM. Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure. Eur Heart J 2001; 22:1136-1143. (Pubitemid 32666655)
12. Zocalli C, Mallamaci F, Parlongo S, Cutrupi S, Benedetto FA, Tripepi G, et al. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease. Circulation 2002; 105:1354-1359. (Pubitemid 34260428)
13. Gold PW, Wong M-L, Goldstein DS, Gold HK, Ronsaville DS, Esler M, et al. Cardiac implications of increased arterial entry and reversible 24-h central and peripheral norepinephrine levels In melancholia. Proc Natl Acad Sci U S A 2005; 102:8303-8308.
14. Carroll BJ. Hypothalamic-pituitary function In depressive illness. Insensitivity to hypoglycemia. BMJ 1969; 3:27-28.
15. Barton DA, Esler MD, Dawood T, Lambert EA, Hailerwal D, Brenchley C, et al. Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy. Arch Gen Psychiatry 2008; 85:1-9.
16. GrassiG,ColomboM,SeravalleG,SpazianiD,ManeiaG. Dissociationbetweenmuscleandskinsympatheticnerveactivityinessentialhypertension, obesity,andcongestiveheartfailure.Hypertension1998;31:64-67.(Pubitemid28124693)
17. Krum H, Schlaioh MP, Whitbourn R, Sobotka P, Sadowskl J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-prlnciple cohort study. Lancet 2009; 373:1275-1281.
18. Esler M, Jennings G, Lambert G, Meredith I, Home M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate and functions. Physiol Rev 1990; 70:963-985.
19. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997; 77:75-197.
20. GlassmanAH,O'ConnorCM,CaliffRM,SwedbergK,BiggerJT,RamaKrishnanKR,etal. SertralinetreatmentofmajordepressioninpatientswithacuteMlorunstableangina. JAMA2002;288:701-709.(Pubitemid34848222)
21. Dawood T, Lambert EA, Barton DA, Laude D, Elghozi J-L, Esler MD, et al. Specific serotonin reuptake inhibition in major depressive disorder adversely affects novel markers of cardiac risk. Hypertens Res 2007; 30:285-293.